Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Health & Fitness
Technology
Sports
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/b0/25/3f/b0253fa0-bb71-a5cd-ad24-dbd57184544d/mza_8311247737997518635.jpg/600x600bb.jpg
The Lancet HIV in conversation with
The Lancet Group
82 episodes
3 days ago
Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s success, the challenges that still lie ahead, and how a current global funding crisis could impact the fight against HIV in the country. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00100-6/fulltext?dgcid=buzzsprou...
Show more...
Medicine
Education,
Health & Fitness,
Science,
Life Sciences
RSS
All content for The Lancet HIV in conversation with is the property of The Lancet Group and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s success, the challenges that still lie ahead, and how a current global funding crisis could impact the fight against HIV in the country. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00100-6/fulltext?dgcid=buzzsprou...
Show more...
Medicine
Education,
Health & Fitness,
Science,
Life Sciences
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/b0/25/3f/b0253fa0-bb71-a5cd-ad24-dbd57184544d/mza_8311247737997518635.jpg/600x600bb.jpg
Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV
The Lancet HIV in conversation with
16 minutes
1 month ago
Richard Wu on a phase 1 trial of a broadly neutralising antibody for HIV
In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00041-4/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanhiv Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup h...
The Lancet HIV in conversation with
Uganda is closer than ever to achieving HIV epidemic control, thanks to remarkable progress in its national response. In this episode, experts Mansoor Farahani, Wafaa El-Sadr, and Wilford L. Kirungi discuss the strategies behind Uganda’s success, the challenges that still lie ahead, and how a current global funding crisis could impact the fight against HIV in the country. Read the full article: https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(25)00100-6/fulltext?dgcid=buzzsprou...